États-Unis · Plateformes & données · Finviz

Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026

Publié par Finviz · États-Unis il y a 3 j

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially…

Lire l'article complet sur Finviz Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finviz.com)

Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026

À lire aussi

Rogers Communications: 3 Key Takeaways for Long-Term Investors

Trump prepares tariff relief on Canada ahead of midterms - report

Think annuities are a rip-off? Now might be the perfect time to reconsider.

Earnings call transcript: Preferred Bank tops Q3 2026 EPS, shares slip premarket

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Amazon's $197 waterproof resin storage cabinet has 2 cabinets and a drawer

Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026

Partager

À lire aussi

Rogers Communications: 3 Key Takeaways for Long-Term Investors

Trump prepares tariff relief on Canada ahead of midterms - report

Think annuities are a rip-off? Now might be the perfect time to reconsider.

Earnings call transcript: Preferred Bank tops Q3 2026 EPS, shares slip premarket

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Amazon's $197 waterproof resin storage cabinet has 2 cabinets and a drawer